• 5 ADC Manufacturing Challenges You Need To Know
    5 ADC Manufacturing Challenges You Need To Know

    The unique targeting capabilities and promising clinical trial results of antibody-drug conjugates (ADCs) have made them an exciting and promising treatment in the fight against cancer. According to recent analysis, experts anticipate the ADC market to be worth $10 billion annually by 2025. However, despite this tremendous growth, drugmakers still face a number of challenges in the manufacturing process for ADCs. Below are five key areas where pharmaceutical manufacturers may face the biggest uphill battles.

  • From Discovery To Development: GS Expression System For Next-Generation Biologics

    Compared to traditional antibody expression, where routine purification and analytical strategies have been established over the last few years, next-generation biologics have complex designs. If you are first in class or you have a very bespoke up- and downstream process, it also means you will have bigger hurdles to overcome when it comes to regulatory support and filing. At Lonza, these challenges are addressed with the GS™ expression platform.

  • Digging Into The Details: Commonly Asked Questions About Lonza’s XS And GS Expression Systems

    No single strain or vector is capable of being the best expression option for all types of biopharmaceuticals. Experts from Lonza answers questions about the proprietary expression platforms the company has assembled to rapidly generate high-producing cell lines for biological candidates.

  • How Pacira Pharma Is Working To Help Curb The Opioid Epidemic

    The most effective way to stop the epidemic of opioid dependence is to eliminate the use of these highly addictive drugs after surgery. This was the goal of Pacira Pharmaceuticals, a specialty pharmaceutical company focused on the development of non-opioid products for postsurgical pain control, when it developed its injectable suspension, EXPAREL®.

  • Early Implementation Of Quality By Design For Biological Product Development

    The idea of thinking in terms of “operational excellence” is a relatively new idea for the biopharmaceutical industry. The enormous uncertainty associated with bringing a biological drug product from discovery to approval almost precludes the thought of forward-thinking in terms of what makes a quality product, especially during early-stage development. However, extensive product knowledge is gathered during early development, and crucial decisions are made in terms moving the science forward to generate the data required to meet your business objectives.

More From Featured Articles


SERA-520 Clinical Analyzer SERA-520 Clinical Analyzer
The SERA-520 is a clinical analyzer designed for the simultaneous measurement of Na+, K+, and Cl- contents of humoralelectrolyte samples, including whole blood, plasma, serum, diaiysate and diluted urine...
2071 3M™ Particulate Filter, P95 2 per BG 2071 3M™ Particulate Filter, P95 2 per BG
The 3M™ 2071 P95 Particulate Filter with Advanced Electret Media technology provides protection in environments where oil, and non-oil based particles are present.
Research Products - HPSA™ IL-1ß            Research Products - HPSA™ IL-1ß
Several fluorescence-based assays that use Chromagen's technologies are available as finished kits for direct sale to biomedical research scientists
Mass Spectrometer Mass Spectrometer
The Aero Vac is a fully computerized mass spectrometer that is used for monitoring and controlling industrial
Integrated NMR Chemical Analyzer Integrated NMR Chemical Analyzer
The Integrated NMR Chemical Analyzer is designed for use by non-NMR-spectroscopists...
Smart Apertured Grazing Angle Accessory (SAGA) Smart Apertured Grazing Angle Accessory (SAGA)
This Smart Apertured Grazing Angle Accessory (SAGA) features a fixed, 80-degree angle of incidence and a permanently-mounted Germanium polarizer.
More Featured Products


CHI's Immunogenicity and Bioassay Summit 2016 October 26 - 28, 2016
Baltimore, MD
Biosimilars 2016 October 27 - 28, 2016
Washington, DC, DC
The Top Method Validation Mistakes – And How to Avoid Them November 2, 2016
1pm-2:30pm EST, Online Training
More Events....


The Top Method Validation Mistakes – And How to Avoid Them November 2, 2016
1pm-2:30pm EST, Online Training
Selecting a CMO/CDMO: 11 Best Practices For Sourcing The Right Partner November 9, 2016
1pm-2:30pm EST, Online Training
Preparing eCTD Submissions: A Step-By-Step Guide November 10, 2016
1pm-2:30pm EDT, Online Training
"Powering Up" Your GMP Training - Make Training Fun! November 16, 2016
1pm-2:30pm EST, Online Training
More Upcoming Courses